Pages that link to "Q73106368"
Jump to navigation
Jump to search
The following pages link to Increased osteoprotegerin serum levels in men with coronary artery disease (Q73106368):
Displaying 50 items.
- Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease (Q26747224) (← links)
- Regulatory circuits controlling vascular cell calcification (Q26825788) (← links)
- Vascular calcification: When should we interfere in chronic kidney disease patients and how? (Q28071582) (← links)
- Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke (Q28078744) (← links)
- Vascular calcification and osteolysis in diabetic neuropathy-is RANK-L the missing link? (Q28278113) (← links)
- Vascular calcification: pathobiology of a multifaceted disease (Q28282418) (← links)
- Cholesterol in vascular and valvular calcification (Q28361780) (← links)
- Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab (Q28727655) (← links)
- Association of serum osteoprotegerin with left ventricular mass in African American adults with hypertension (Q30477731) (← links)
- Serum osteoprotegerin and renal function in the general population: the Tromsø Study (Q33793497) (← links)
- Circulating osteoprotegerin is associated with chronic kidney disease in hypertensive patients (Q33882341) (← links)
- Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus (Q34399438) (← links)
- Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis. (Q34412603) (← links)
- Elevated levels of plasma osteoprotegerin are associated with all-cause mortality risk and atherosclerosis in patients with stages 3 to 5 chronic kidney disease (Q34502634) (← links)
- Clinical, microbiological, and salivary biomarker profiles of dental implant patients with type 2 diabetes (Q34965471) (← links)
- TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL. (Q34989869) (← links)
- The roles of lipid oxidation products and receptor activator of nuclear factor-κB signaling in atherosclerotic calcification (Q35083231) (← links)
- Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis. (Q35125558) (← links)
- Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study (Q35152081) (← links)
- Skeleton and glucose metabolism: a bone-pancreas loop (Q35250223) (← links)
- An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction (Q35569854) (← links)
- (Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis. (Q35620276) (← links)
- Association of plasma osteoprotegerin levels with the severity of lower extremity arterial disease in patients with type 2 diabetes (Q35742069) (← links)
- Adverse effects of hyperlipidemia on bone regeneration and strength (Q35742748) (← links)
- Osteoprotegerin secreted by inflammatory and invasive breast cancer cells induces aneuploidy, cell proliferation and angiogenesis (Q35853271) (← links)
- Polymorphisms in three genes are associated with hemorrhagic stroke (Q35868148) (← links)
- Osteoprotegerin Prevents Development of Abdominal Aortic Aneurysms (Q35897444) (← links)
- Osteoprotegerin/RANKL axis and progression of coronary artery calcification in hemodialysis patients (Q35995048) (← links)
- Serum osteoprotegerin is associated with pulse pressure in kidney transplant recipients (Q36149956) (← links)
- Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function (Q36295418) (← links)
- Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis (Q36326701) (← links)
- The immune response is involved in atherosclerotic plaque calcification: could the RANKL/RANK/OPG system be a marker of plaque instability? (Q36470227) (← links)
- Enhanced mineralization potential of vascular cells from SM22α-Rankl (tg) mice (Q36470803) (← links)
- Correlation of plasma osteoprotegerin (OPG) and receptor activator of the nuclear factor κB ligand (RANKL) levels with clinical risk factors in patients with advanced carotid atherosclerosis (Q36576768) (← links)
- Osteoprotegerin as a marker of atherosclerosis in diabetic patients. (Q36582644) (← links)
- Circulating RANKL is inversely related to RANKL mRNA levels in bone in osteoarthritic males. (Q36641523) (← links)
- Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. (Q36860987) (← links)
- Osteoprotegerin is an independent predictor of vascular events in Finnish adults with type 1 diabetes (Q36942172) (← links)
- Association between osteoprotegerin gene polymorphisms and cardiovascular disease in type 2 diabetic patients (Q37024429) (← links)
- Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis (Q37035270) (← links)
- Expression and regulation of osteoprotegerin in adipose tissue (Q37065591) (← links)
- Role of Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand in Bone Loss Related to Advanced Chronic Obstructive Pulmonary Disease (Q37126218) (← links)
- Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities? (Q37176133) (← links)
- Osteoprotegerin, vascular calcification and atherosclerosis (Q37310825) (← links)
- Early Atherosclerosis in HIV Infected Subjects on Suppressive Antiretroviral Treatment: Role of Osteoprotegerin (Q37408169) (← links)
- The link between osteoporosis and cardiovascular disease. (Q37430306) (← links)
- Increased bone resorption is associated with increased risk of cardiovascular events in men: the MINOS study. (Q37469378) (← links)
- Medial arterial calcification in diabetes and its relationship to neuropathy. (Q37597984) (← links)
- Association of Osteoprotegerin with Obesity, Insulin Resistance and Non-Alcoholic Fatty Liver Disease in Children. (Q37627672) (← links)
- RANKL enhances macrophage paracrine pro-calcific activity in high phosphate-treated smooth muscle cells: dependence on IL-6 and TNF-α. (Q37727115) (← links)